Compounds block a protein involved in many cancers by cementing it shut.

Compounds that block the production of damaging molecules might shed light on their role in disease—and lead to new therapies.

Researchers improve our understanding about how compounds bind to proteins in the cell membrane—and the membrane itself.

Novartis opens up a path of research to protect proteins that guard against cancer.

Read how a genetics postdoctoral researcher finds Huntington's mutation travels through neural circuits.

One patient’s story reveals the hidden obstacles to better health – and opportunities to help clear them.

Zebrafish imaging sheds light on human neurological conditions.

Novel PRC2 inhibitor changes the expression of hundreds of genes in lab model

Most people have never heard of spinal muscular atrophy (SMA), a rare genetic disease that affects approximately 1 in 6,000 babies born worldwide each year. Innovative research may produce treatments for patients suffering from SMA and other rare diseases.